Author

J. S. Weinstein

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 3 Bioengineering· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 5 Research Focus:host-pathogen & immune response· 4 Organism:mouse· 4 Research Focus:cell signaling & trafficking· 2 Research Focus:cell type annotation· 2 Research Focus:development & morphogenesis· 2 Research Focus:drug response / drug discovery· 2 Assay:bulk RNA-seq· 1

Frequent Co-Authors

P. O. Scumpia· 3 shared D. Di Carlo· 2 shared D. P. Mayer· 2 shared J. S. Chen· 2 shared M. M. Archang· 2 shared O. Q. Antao· 2 shared A. C. Feng· 1 shared A. Iwasaki· 1 shared

Activity by Year

2020-2024 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 18 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersBioengineering

P. O. Scumpia

Mutual co-authors in cluster

Author profile →

5 papers

Recent·Most cited

A novel microporous biomaterial vaccine platform for long-lasting antibody mediated immunity against viral infection.

D. P. Mayer, M. Nelson, D. Andriyanova, O. Q. Antao, J. S. Chen, P. O. Scumpia, W. M. Weaver, S. Deshayes, J. S. Weinstein

This paper develops a novel microporous biomaterial vaccine platform, VaxMAP, which enhances antibody-mediated immunity against viral infections compared to traditional vaccines.

bioRxiv · Jan 30, 2024Immunology

Improved humoral immunity and protection against influenza virus infection with a 3D porous biomaterial vaccine

H. Miwa, O. Q. Antao, K. M. Kelly-Scumpia, S. Baghdasarian, D. P. Mayer, L. Shang, G. M. Sanchez, M. M. Archang, P. O. Scumpia, J. S. Weinstein, D. Di Carlo

This paper develops a 3D porous biomaterial vaccine platform that enhances humoral immunity and protection against influenza virus by tuning physical and chemical properties.

bioRxiv · Dec 16, 2022Bioengineering

High-affinity, neutralizing antibodies to SARS-CoV-2 can be made in the absence of T follicular helper cells

J. S. Chen, R. D. Chow, E. Song, T. Mao, B. Israelow, K. Kamath, J. Bozekowski, W. A. Haynes, R. B. Filler, B. L. Menasche, J. Wei, M. M. Alfajaro, W. Song, L. Peng, L. Carter, , S. C. Eisenbarth

The paper shows that high-affinity, neutralizing antibodies against SARS-CoV-2 can be produced without T follicular helper cells through alternative pathways.

bioRxiv · Jun 10, 2021Immunology

Lung macrophages mediate helminth resistance through differential activation of recruited monocyte-derived alveolar macrophages and arginine depletion

F. Chen, D. W. El-Naccache, J. J. Ponessa, A. Lemenze, V. Espinosa, W. Wu, K. Lothstein, L. Jin, O. Antao, J. S. Weinstein, P. Damani-Yokota, K. Khanna, P. J. Murray, A. Rivera, M. C. Siracusa, W. C. Gause

This study identifies lung macrophages that kill helminths by depleting arginine through differential activation of recruited monocyte-derived alveolar macrophages.

bioRxiv · Oct 2, 2020 · PreprintImmunology

Activating an adaptive immune response from a hydrogel scaffold imparts regenerative wound healing.

D. R. Griffin, M. M. Archang, C. H. Kuan, W. Weaver, J. S. Weinstein, A. C. Feng, A. Ruccia, E. Sideris, V. Ragkousis, J. Koh, M. V. Plikus, D. Di Carlo, T. Segura, P. O. Scumpia

This study shows that D-peptide crosslinked hydrogels induce adaptive immune responses that promote regenerative wound healing despite faster degradation.

bioRxiv · May 27, 2020Bioengineering